Human Genetics Market Research Report - Forecast to 2027

Human Genetics Market Research Report: By Instrument (Accessories, Device), Method (Prenatal, Molecular, Cytogenetic, Presymptomatic), Application (Forensic Research, Cancer, Cardiovascular Diseases), and End User (Hospitals) – Global Forecast Till 2027

ID: MRFR/LS/0243-HCR | February 2021 | Region: Global | 80 pages

Please note that the assessment period of report has been updated from 2017–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market scenario


Genetics is nothing but the study of genes, their functions and effects. Molecular genetics, developmental genetics, population genetics and quantitative genetics, and human genetics are various types of genetic studies. Human genetics is the study of inheritance in human beings, i.e., it is the study of inheritance of characteristics in children from parents. It includes the study of gene expression, gene structure, mutation analysis, cytogenetics and genomic imaging, genome structure and organization, genetic and physical mapping, disease association studies, molecular diagnostics, genetics of complex diseases, epistatic interactions, and various other concepts. It also helps to determine various genetic factors responsible for diseases. It offers various advantages such as identification and diagnosis and treatment of various diseases such as cancer, cardiovascular diseases, and other genetic diseases.


The global human genetics market is driven by the increasing number of patients with genetic diseases and increasing healthcare expenditure by major economies across the globe.  Furthermore, the growing awareness about genetic diseases, increasing investments in research and development, and rising government support fuel the market growth. However, various factors restrain the growth of the market such as higher cost of instruments and lack of skilled professionals.


Global Human Genetics Market is expecting a healthy growth at a CAGR of 11.5% during the forecast period.


Intended Audience



  • Research and Development (R&D) Companies

  • Genetics & Genomic Industries

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Figure 1- Global Human Genetics Market, by Region


 human genetics market


Source: Annual reports, press release, white paper, company presentation


Segmentation


The global human genetics market is segmented by instruments, methods, applications, and end-users.


On the basis of instruments, it is segmented into accessories and devices.


On the basis of methods, it is segmented into prenatal, molecular, cytogenetic, and presymptomatic.


On the basis of applications, it is segmented into forensic research, cancer, cardiovascular diseases, diabetes, genetic diseases, and others.


On the basis of end-users, it is segmented into hospitals, forensic laboratories, research centers, and others.


 Market Assessment


 human genetics Assessment


Source; World Health Organization (WHO, white paper, company presentation, annual reports


Regional analysis


America is the largest market for human genetics owing to the development in the diagnostics and medical technology and extensive use of new technologies in genetics. Additionally, the presence of key players in the market also fuels the market growth. The U.S. is the largest market for human genetics with an increase in the number of studies in genetics and its importance in healthcare.


The European market for human genetics is driven by the rising prevalence of different chronic genetic diseases and increasing government support for research and development activities. In Germany, being the largest market, the growth is governed by the rising focus on research activities by major market players in the field of genetics and technological advancement.


In Asia Pacific, the market is fueled by the increasing awareness about research in genetic diseases and steady rise in the prevalence of genetic diseases. Major countries contributing to the market growth are China, Japan, and India due to increasing availability of research facilities and presence of skilled workforce such as research scientists and others. Additionally, the increasing number of research institutes focusing on the diagnosis and treatment of genetic diseases with the help of human genetics and increasing availability of funds for research in the field of genetics support the growth of the market.


The Middle East and Africa holds the least share in the global human genetics market and shows a steady growth due to the rising demand for healthcare services and research activities, poor economic condition, and less development in medical facilities, especially, in Africa.


Key players


Some of the major players in the global human genetics market are Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific, Inc. (U.S.).



Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Human Genetics Market, by Method

6.1 Introduction

6.2 Cytogenetic

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Molecular

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Presymptomatic

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Prenatal

6.5.1 Market Estimates & Forecast, 2020-2027

7. Global Human Genetics Market, by Product

7.1 Introduction

7.2 Consumables

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Devices

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Accessories

7.4.1 Market Estimates & Forecast, 2020-2027

8. Global Human Genetics Market, by Application

8.1 Introduction

8.2 Research

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostic

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Forensic Science

8.4.1 Market Estimates & Forecast, 2020-2027

9. Global Human Genetics Market, by End-User

9.1 Introduction

9.2 Hospital and Clinics

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Diagnostic Centers

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Research Centers

9.4.1 Market Estimates & Forecast, 2020-2027

9.5 Forensic Departments

9.5.1 Market Estimates & Forecast, 2020-2027

10. Global Human Genetics Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K.

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Agilent Technologies

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 Key Developments

12.2 Bode Technology

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.3 GE Healthcare

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.4 Illumina

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.5 LGC Forensics

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Orchid Cellmark, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Promega Corporation

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Human Genetics Industry

14 Appendix


LIST OF TABLES

Table 1 Human Genetics Industry Synopsis, 2020-2027

Table 2 Global Human Genetics Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Human Genetics Market, by Region, 2020-2027, (USD Million)

Table 4 Global Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 5 Global Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 6 Global Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 7 Global Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 8 North America Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 9 North America Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 10 North America Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 11 North America Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 12 US Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 13 US Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 14 US Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 15 US Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 16 Canada Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 17 Canada Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 18 Canada Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 19 Canada Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 20 South America Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 21 South America Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 22 South America Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 23 South America Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 24 Europe Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 25 Europe Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 26 Europe Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 27 Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 28 Western Europe Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 29 Western Europe Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 30 Western Europe Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 31 Western Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 32 Eastern Europe Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 33 Eastern Europe Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 34 Eastern Europe Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 35 Eastern Europe Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 36 Asia Pacific Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 37 Asia Pacific Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 38 Asia Pacific Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 39 Asia Pacific Human Genetics Market, by End-User, 2020-2027, (USD Million)

Table 40 Middle East & Africa Human Genetics Market, by Method, 2020-2027, (USD Million)

Table 41 Middle East & Africa Human Genetics Market, by Product, 2020-2027, (USD Million)

Table 42 Middle East & Africa Human Genetics Market, by Application, 2020-2027, (USD Million)

Table 43 Middle East & Africa Human Genetics Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Human Genetics Market

Figure 3 Segmentation Market Dynamics for Human Genetics Market

Figure 4 Global Human Genetics Market Share, by Product 2016

Figure 5 Global Human Genetics Market Share, by Application 2016

Figure 6 Global Human Genetics Market Share, by End-User, 2016

Figure 7 Global Human Genetics Market Share, by Region, 2016

Figure 8 North America Human Genetics Market Share, by Country, 2016

Figure 9 Europe Human Genetics Market Share, by Country, 2016

Figure 10 Asia Pacific Human Genetics Market Share, by Country, 2016

Figure 11 Middle East & Africa Human Genetics Market Share, by Country, 2016

Figure 12 Global Human Genetics Market: Company Share Analysis, 2016 (%)

Figure 13 AGILENT TECHNOLOGIES: Key Financials

Figure 14 AGILENT TECHNOLOGIES: Segmental Revenue

Figure 16 AGILENT TECHNOLOGIES: Geographical Revenue

Figure 17 Bode Technology: Key Financials

Figure 18 Bode Technology: Segmental Revenue

Figure 19 Bode Technology: Geographical Revenue

Figure 20 GE Healthcare: Key Financials

Figure 21 GE Healthcare: Segmental Revenue

Figure 22 GE Healthcare: Geographical Revenue

Figure 23 QIAGEN N.V.: Key Financials

Figure 24 QIAGEN N.V.: Segmental Revenue

Figure 25 QIAGEN N.V.: Geographical Revenue

Figure 26 Orchid Cellmark, Inc.: Key Financials

Figure 27 Orchid Cellmark, Inc.: Segmental Revenue

Figure 28 Orchid Cellmark, Inc.: Geographical Revenue

Figure 29 LGC Forensics: Key Financials

Figure 30 LGC Forensics: Segmental Revenue

Figure 31 LGC Forensics: Geographical Revenue